Home
About Character
Careers
News
NEW
Home
About Character
Careers
News
NEW
media
Character Bio at ARVO 2024
Character Bio unveils its two drug programs and stem cell platform at ARVO 2024.
Read on Medium
5/24
Welcoming Dr. Laura Carter
Laura Carter, Ph.D, joins Character Bio as Chief Scientific Officer
Read press release
9/23
Home
About Character
Careers
News
NEW
Funding and rebrand announcement
Character Biosciences raises new funding round to accelerate the development of targeted therapies for diseases of aging.
Read press release
5/22
Innovation Endeavors: Deep characterization of disease
Our lead investor explains their investment thesis in Character
Read on Medium
5/22
Cantos Ventures: Precision medicine meets drug discovery
Cantos describes why they have chosen to partner with Character through multiple rounds of financing
Read on Medium
5/22
Vivek: Character Biosciences milestone
The CEO of Clover Health details the aligned missions for Clover & Character and our progress
Read on Medium
5/22
Cheng: A patient-driven therapeutics company
Our CEO shares Character's patient-first DNA
Read on Medium
7/19